Epac activation increased MYPT phosphorylation via PLC/PKC. by Yoshiki Ohnuki (576298)

Subjects:

Hydrate-Based Gas Storage Made Greener: Methane Hydrate Formation Enhancement with a Low-Toxicity Promoter by Katipot Inkong (7979942)

Subjects:

Hydrate-Based Gas Storage Made Greener: Methane Hydrate Formation Enhancement with a Low-Toxicity Promoter by Katipot Inkong (7979942)

Subjects:

Overall cardiovascular disease 2^nd level risk factors rank ordered by attributed DALYs in 1990 and 2021 for females (above) and males (below) in Chile. Red. by Camilo Briones-Valdivieso (21567535)

Subjects:

Relative change in cardiovascular diseases DALYs rates from 1990-1994 to 2017-2021 in Chile, for both genders. by Camilo Briones-Valdivieso (21567535)

Subjects:

Cardiovascular diseases ranked by DALYs in 1990 and 2021 for females (above) and males (below) in Chile. by Camilo Briones-Valdivieso (21567535)

Subjects:

Hydrate-Based Gas Storage Made Greener: Methane Hydrate Formation Enhancement with a Low-Toxicity Promoter by Katipot Inkong (7979942)

Subjects:

Hydrate-Based Gas Storage Made Greener: Methane Hydrate Formation Enhancement with a Low-Toxicity Promoter by Katipot Inkong (7979942)

Subjects:

Overall CVD disease burden in DALYs attributable to 1^st-level risk factors in Chile. DALYs rates are expressed per 100,000 individuals, with a 95% uncertainty interval. by Camilo Briones-Valdivieso (21567535)

Subjects:

Hydrate-Based Gas Storage Made Greener: Methane Hydrate Formation Enhancement with a Low-Toxicity Promoter by Katipot Inkong (7979942)

Subjects:

Overall cardiovascular disease DALYs age-standardised rate over time 1990-2021 in Chile. by Camilo Briones-Valdivieso (21567535)

Subjects:

Hydrate-Based Gas Storage Made Greener: Methane Hydrate Formation Enhancement with a Low-Toxicity Promoter by Katipot Inkong (7979942)

Subjects:

Hydrate-Based Gas Storage Made Greener: Methane Hydrate Formation Enhancement with a Low-Toxicity Promoter by Katipot Inkong (7979942)

Subjects:

Hydrate-Based Gas Storage Made Greener: Methane Hydrate Formation Enhancement with a Low-Toxicity Promoter by Katipot Inkong (7979942)

Subjects:

Percentage distribution of DALYs for cardiovascular diseases in 2021 in Chile. by Camilo Briones-Valdivieso (21567535)

Subjects:

Phosphorylation status of myofilament proteins prepared from Epac1TG. by Yoshiki Ohnuki (576298)

Subjects:

Mean liver weight (g) (A), liver weight/body ratio (B), hepatic triglyceride (mg/g) (C) and hepatic steatosis quantification (% area) (D) upon completion of the treatment phase. by Elsie D. Oduor (22521785)

Subjects:

Epac activation with 8CPT-AM induced RLC phosphorylation in the perfused hearts. by Yoshiki Ohnuki (576298)

Subjects:

Epac activation increased RLC phosphorylation via PLC/PKC. by Yoshiki Ohnuki (576298)

Subjects:

TBSS results showing significant AxD and RD changes at baseline and the follow-up. by Sewon Lim (21989785)

“…The decreased diffusivity metrics (AxD and RD) exhibited no statistically significant differences at <i><i>P</i></i> < 0.05 after correcting for multiple comparisons (FWE). …”